Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Oncology|January 14, 2020
Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based ChemotherapySabrina Borchert, Pia-Maria Suckrau, Michael Wessolly, et al.
Cancers|March 25, 2022
Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and NeckJohannes Doescher, Moritz Meyer, Christoph Arolt, et al.
Scientific Reports|October 30, 2020
Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesotheliomaSabrina Borchert, Pia-Maria Suckrau, Robert F H Walter, et al.
Cell Reports|August 17, 2022
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesEkaterina Pylaeva, Georg Korschunow, Ilona Spyra, et al.
Cancer Immunology, Immunotherapy : CII|November 29, 2023
HPV-associated head and neck cancer is characterized by distinct profiles of CD8<sup>+</sup> T cells and myeloid-derived suppressor cellsBenjamin A Kansy, Tim P Wehrs, Kirsten Bruderek, et al.
Oncotarget|June 2, 2018
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapyFabian D Mairinger, Jan Schmeller, Sabrina Borchert, et al.
Scientific Reports|April 3, 2020
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibitionBahil Ghanim, Anna Rosenmayr, Paul Stockhammer, et al.
Journal of Oncology|August 17, 2018
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53Robert F H Walter, Robert Werner, Michael Wessolly, et al.
Immunobiology|November 23, 2016
Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survivalHana Guberina, Vera Rebmann, Bettina Wagner, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 yearsBerit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Pageof 8